
BIOLASE BIOL
Quarterly report 2024-Q3
added 05-30-2026
BIOLASE P/CF Ratio 2011-2026 | BIOL
Annual P/CF Ratio BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0136 | -0.00098 | -0.0327 | -5.4 | -27.3 | -66.2 | -42.1 | -223 | -2.98 | -7.02 | -1.06 K | -6.07 K | -853 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.00098 | -6.07 K | -643 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
-1.31 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
-13.2 | $ 17.77 | 5.71 % | $ 503 M | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.7 | $ 8.81 | 6.92 % | $ 1.32 B | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-24.8 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-244 | $ 1.62 | 1.25 % | $ 35.7 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.13 | -3.42 % | $ 19.1 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.44 | -8.11 % | $ 27.4 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-90 | $ 18.87 | 3.85 % | $ 443 M | ||
|
Delcath Systems
DCTH
|
14.5 | $ 11.69 | -2.01 % | $ 419 M | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Pulmonx Corporation
LUNG
|
-2.25 | $ 1.28 | 2.4 % | $ 52.1 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
LivaNova PLC
LIVN
|
15 | $ 78.5 | - | $ 4.28 B | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
-4.81 | $ 5.74 | -8.31 % | $ 68.6 M | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Orthofix Medical
OFIX
|
14.7 | $ 9.45 | 2.38 % | $ 374 M | ||
|
Electromed
ELMD
|
15.3 | $ 38.68 | 4.15 % | $ 327 M | ||
|
MiMedx Group
MDXG
|
10.5 | $ 3.67 | 1.66 % | $ 542 M | ||
|
Butterfly Network
BFLY
|
-74.5 | $ 8.9 | 55.87 % | $ 2.2 B | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
-2.34 | $ 1.28 | -10.8 % | $ 53.6 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
16.6 | $ 79.23 | 5.05 % | $ 10.7 B | ||
|
Profound Medical Corp.
PROF
|
-4.34 | $ 6.87 | 4.57 % | $ 208 M | ||
|
Insulet Corporation
PODD
|
31.9 | $ 145.76 | 1.56 % | $ 10.3 B | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 32.58 | 1.46 % | $ 1.01 B | ||
|
Inspire Medical Systems
INSP
|
15.1 | $ 42.61 | 3.62 % | $ 1.25 B | ||
|
Integer Holdings Corporation
ITGR
|
15.2 | $ 90.96 | 1.63 % | $ 3.16 B | ||
|
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
30.6 | $ 87.36 | 0.78 % | $ 51.1 B | ||
|
Sintx Technologies
SINT
|
-0.806 | $ 2.11 | 3.94 % | $ 5.85 M |